Ruikang Pharma can't be compared to China Resources Pharmaceuticals

Ruikang Pharmaceutical and China Resources Pharmaceutical can not be compared. Ruikang Pharmaceutical and China Resources Pharmaceutical are both large pharmaceutical companies in China, but they have some differences in business scope, product line, market share and so on. First of all, Ruikang Pharma is mainly engaged in the business of medical devices, medical services, and pharmaceutical distribution, while CRRC Pharma covers the fields of pharmaceutical manufacturing, pharmaceutical distribution, and pharmaceutical retailing. Therefore, the business scope of Ruikang Pharma is relatively narrow, while CRH Pharma is more diversified. Secondly, Ruikang Pharma has certain advantages in the field of medical devices, and its product line covers a number of segments, such as operating room equipment, medical consumables, medical equipment, and so on. On the other hand, CR Pharma excels in pharmaceutical manufacturing, as it has several production bases and R&D centers, and produces medicines covering several therapeutic areas, such as cardiovascular, neurological, and oncology. Finally, in terms of market share, Ruikang Pharma holds a certain market share in the medical device sector, while CR Pharma is a leader in pharmaceutical manufacturing and distribution. In summary, there are differences between Ruikang Pharmaceutical and CRH Pharmaceutical in terms of business scope, product line and market share, making it difficult to make a direct comparison.